Document is current
Any future updates will be listed below
-
Authors
Colin-Leitzinger, Christelle
Lawson-Michod, Katherine A.
Johnson, Courtney E.
Vlasac, Irma M.
Yoder, Sean
Mesa, Tania
Roeber, Dana
Huff, Chad
Hildebrandt, Michelle A. T.
Haller, Kristin
Alberg, Anthony J.
Bandera, Elisa V.
Bondy, Melissa
Cote, Michele L.
Hastert, Theresa
Peters, Edward S.
Terry, Paul D.
Lawson, Andrew B.
Berchuck, Andrew
Fridley, Brooke L.
Chern, Jing-Yi
Doherty, Jennifer A.
Marks, Jeffrey R.
Schildkraut, Joellen M.
Christensen, Brock C.
Salas, Lucas A.
Peres, Lauren C.
-
Funding
Funding for this research was provided by:
NIH/NCI R01 (CA188943, CA188943, CA237318, CA188943, CA275974)
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 12 July 2025
First Online: 30 July 2025
Declarations
:
: LCP reports research funding from Bristol Myers Squibb, Karyopharm, and Janssen unrelated to this work. LS and BC are Advisors and co-founders of Cellintec LLC which had no role in this study. BC is an advisor to Guardant Health which had no role in this study. MLC reports personal fees from Ashcragt & Gerel, unrelated to this work. KLM reports personal fees from Epidemiologic Research and Methods LLC for work unrelated to the present research. JYC reports consulting and speaker’s bureau for Astrazeneca and consulting for Cardinal Health, Rockner Health, and Association of Cancer Care Centers unrelated to this work.
